New Key Statistics Module, Z-Score and F-Score
SHSE:688105 Key Ratios
Market Cap ¥ M | 8,103.00 |
Enterprise Value ¥ M | 6,081.71 |
P/E(ttm) | 353.51 |
PE Ratio without NRI | 119.23 |
Forward PE Ratio | 37.51 |
Price/Book | 2.05 |
Price/Sales | 5.36 |
Price/Free Cash Flow | 341.53 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.59 |
Revenue (TTM) ¥ M | 1,402.00 |
EPS (TTM) ¥ | 0.06 |
Beneish M-Score | -1.29 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 396.15 |
EV-to-EBITDA | 396.15 |
PEG | -- |
Shares Outstanding M | 402.13 |
Net Margin (%) | 1.68 |
Operating Margin % | 2.82 |
Pre-tax Margin (%) | -1.12 |
Quick Ratio | 4.17 |
Current Ratio | 4.69 |
ROA % (ttm) | 0.44 |
ROE % (ttm) | 0.59 |
ROIC % (ttm) | -2.21 |
Dividend Yield % | 0.64 |
Altman Z-Score | 6.18 |
SHSE:688105 Number of Guru Trades
SHSE:688105 Volume of Guru Trades
Gurus Latest Trades with SHSE:688105
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688105 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Vazyme Biotech Co Ltd Insider Transactions
No Available Data